Literature DB >> 31521850

A clinical and epidemiological survey of the largest dengue outbreak in Southern Taiwan in 2015.

Wen-Hung Wang1, Chih-Yen Lin2, Ko Chang3, Aspiro Nayim Urbina4, Wanchai Assavalapsakul5, Arunee Thitithanyanont6, Po-Liang Lu7, Yen-Hsu Chen8, Sheng-Fan Wang9.   

Abstract

OBJECTIVES: This study examined the epidemiological, clinical, and immunological characteristics of the 2015 dengue outbreak in Taiwan.
METHODS: Clinical data were collected from dengue fever (DF) and dengue hemorrhagic fever (DHF) patients. A phylogenetic tree was used to analyze the source of the outbreak strain. Paired plasma samples from DF/DHF patients were used for antibody-dependent enhancement (ADE) assay and cytokine multiplex biometric immunoassay to validate the immunological mechanism.
RESULTS: This outbreak mainly occurred in two of the southern cities of Taiwan: Tainan (n=22 777; 52%) and Kaohsiung (n=19 784; 45%). A high DHF death rate was noted (34.6%). The case (DHF) and control (DF) study indicated that older age (>60 years), type II diabetes, and hypertension were risk factors correlated with the development of DHF (p< 0.0001). The phylogenetic tree results suggested that the outbreak-associated strain was dengue virus serotype 2 and cosmopolitan genotype, forming a stable cluster with the isolates from Thailand and Indonesia (bootstrap value of 99%). Cytokine analyses demonstrated that levels of interleukin (IL)-6, IL-4, IL-13, IL-1β, interferon gamma (IFN-γ), and granulocyte-macrophage colony-stimulating factor (GM-CSF) were significantly higher in DHF patients compared to DF patients (p< 0.001). The ADE assay showed that diluted plasma containing preexisting dengue antibodies from DHF patients significantly enhanced dengue infection (p< 0.05).
CONCLUSION: The results suggest that older age, type II diabetes, hypertension, immunological cytokine dysregulation, and preexisting dengue antibodies inducing ADE infection are correlated with dengue severity. This study also indicates that the largest dengue outbreak in Taiwan might have been a result of imported DF from dengue epidemic regions.
Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Antibody-dependent enhancement; Dengue fever; Dengue hemorrhagic fever; Risk factors; Taiwan

Mesh:

Substances:

Year:  2019        PMID: 31521850     DOI: 10.1016/j.ijid.2019.09.007

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  7 in total

1.  Acute-phase Serum Cytokine Levels and Correlation with Clinical Outcomes in Children and Adults with Primary and Secondary Dengue Virus Infection in Myanmar between 2017 and 2019.

Authors:  Khine Mya Nwe; Mya Myat Ngwe Tun; Theingi Win Myat; Chris Fook Sheng Ng; Moh Moh Htun; Htin Lin; Nang Sarm Hom; Aung Min Soe; Annie Elong Ngono; Shinjiro Hamano; Kouichi Morita; Kyaw Zin Thant; Sujan Shresta; Hlaing Myat Thu; Meng Ling Moi
Journal:  Pathogens       Date:  2022-05-09

Review 2.  IL-18: The Forgotten Cytokine in Dengue Immunopathogenesis.

Authors:  Josephine Diony Nanda; Tzong-Shiann Ho; Rahmat Dani Satria; Ming-Kai Jhan; Yung-Ting Wang; Chiou-Feng Lin
Journal:  J Immunol Res       Date:  2021-11-19       Impact factor: 4.818

3.  Serum IL-18 Is a Potential Biomarker for Predicting Severe Dengue Disease Progression.

Authors:  Josephine Diony Nanda; Chiau-Jing Jung; Rahmat Dani Satria; Ming-Kai Jhan; Ting-Jing Shen; Po-Chun Tseng; Yung-Ting Wang; Tzong-Shiann Ho; Chiou-Feng Lin
Journal:  J Immunol Res       Date:  2021-10-25       Impact factor: 4.818

4.  Dengue virus co-opts innate type 2 pathways to escape early control of viral replication.

Authors:  Gathsaurie N Malavige; Graham S Ogg; Chathuranga L Fonseka; Clare S Hardman; Jeongmin Woo; Randeep Singh; Janina Nahler; Jiahe Yang; Yi-Ling Chen; Achala Kamaladasa; Tehani Silva; Maryam Salimi; Nicki Gray; Tao Dong
Journal:  Commun Biol       Date:  2022-07-22

5.  Senescence in Monocytes Facilitates Dengue Virus Infection by Increasing Infectivity.

Authors:  Tzu-Han Hsieh; Tsung-Ting Tsai; Chia-Ling Chen; Ting-Jing Shen; Ming-Kai Jhan; Po-Chun Tseng; Chiou-Feng Lin
Journal:  Front Cell Infect Microbiol       Date:  2020-07-28       Impact factor: 5.293

6.  Risk Factors for Elevated Serum Lipopolysaccharide in Acute Dengue and Association with Clinical Disease Severity.

Authors:  N L Ajantha Shyamali; Sameera D Mahapatuna; Laksiri Gomes; Ananda Wijewickrama; Graham S Ogg; Gathsaurie Neelika Malavige
Journal:  Trop Med Infect Dis       Date:  2020-11-16

Review 7.  Dysfunctional Innate Immune Responses and Severe Dengue.

Authors:  Gathsaurie Neelika Malavige; Chandima Jeewandara; Graham S Ogg
Journal:  Front Cell Infect Microbiol       Date:  2020-10-23       Impact factor: 5.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.